NIM811|(Melle-4)cyclosporin|143205-42-9|NIM-811|Sdz-nim-811|Sdz nim811|NIM 811|9-(N-methyl-L-isoleucine)-cyclosporin A|CHEMBL1688529|96262S4I14|Cyclosporin A, 9-(N-methyl-L-isoleucine)-|Sdz nim 811|UNII-96262S4I14|[MeIle]4-CsA|[MeIle]4-Ciclosporin|[MeIle]
Specifications & Purity
≥99%
Biochemical and Physiological Mechanisms
NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailable mitochondrial permeability transition and cyclophilin dual inhibitor, which exhibits potent in vitro activity against hepatitis C virus (HCV).
Storage Temp
Desiccated,Store at -80°C
Shipped In
Ice chest + Ice pads
Product Description
NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailable mitochondrial permeability transition and cyclophilin dual inhibitor, which exhibits potent in vitro activity against hepatitis C virus (HCV)
In Vitro
NIM811 induces a concentration-dependent reduction of HCV RNA in the replicon cells with an IC 50 of 0.66 μM at 48 h. In addition, the combination of NIM811 with a-IFN significantly enhances anti-HCV activities without causing any increase of cytotoxicity. NIM811 blocks the mitochondrial permeability transition induced by calcium and inorganic phosphate. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
NIM811 prevents mitochondrial depolarization thereby attenuates liver injury, stimulates regeneration and improves liver function and survival. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
